Autor: |
Randall, R. W., Eakins, K. E., Higgs, G. A., Salmon, J. A., Tateson, J. E. |
Zdroj: |
Inflammation Research; December 1980, Vol. 10 Issue: 6 p553-555, 3p |
Abstrakt: |
Arachidonic acid is metabolized via two pathways in leukocytes: cyclo-oxygenase, leading to the stable prostaglandins, and lipoxygenase, leading to hydroxyacids. Indomethacin inhibits the cyclo-oxygenase selectively, whereas compound BW755C (3-amino-1-(m-(trifluoromethyl)phenyl)-2-pyrazoline) inhibits both pathways equally. This offers a possible explanation for the differing activities of these two compounds in inflammatory models in vivo. The patterns of product inhibition by the two compounds support the suggestion that 11-HETE (hydroxy-eicosatetraenoic acid) and 15-HETE can arise by incomplete operation of the cyclo-oxygenase pathway. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|